The invention relates to novel compounds of Formula I:
wherein A
1
, A
2
, A
3
, A
4
, A
5
, A
6
, R
2
, R
4
, R
5
, R
6
, R
7
, R
8
and subscripts m and n each has the meaning as described herein. Compounds of Formula I and pharmaceutical compositions thereof are useful in the treatment of disease and disorders in which undesired or over-activation of NF-kB signaling is observed.
The invention relates to novel compounds of Formula I:
wherein A1, A2, A3, A4, A5, A6, R2, R4, R5, R6, R7, R8 and subscripts m and n each has the meaning as described herein. Compounds of Formula I and pharmaceutical compositions thereof are useful in the treatment of disease and disorders in which undesired or over-activation of NF-kB signaling is observed.
[EN] TRICYCLIC COMPOUNDS AND METHODS OF USE THEREFOR<br/>[FR] COMPOSÉS TRICYCLIQUES ET MÉTHODES D'UTILISATION CORRESPONDANTES
申请人:HOFFMANN LA ROCHE
公开号:WO2013120980A1
公开(公告)日:2013-08-22
The invention relates to novel compounds of Formula I: wherein A1, A2, A3, A4, A5, A6, R2, R4, R5, R6, R7, R8 and subscripts m and n each has the meaning as described herein. Compounds of Formula I and pharmaceutical compositions thereof are useful in the treatment of disease and disorders in which undesired or over-activation of NF-kB signaling is observed.
Observations on the Synthesis and Carbocyclisation Reactions of 6-Oxohexa-2,3-dienoates
prepared via an atom economical Claisen rearrangement of propargyl vinyl ethers formed in situ by the reaction of propargylic alcohols with acetals. Preliminary experiments have demonstrated that these functionalised allenic esters undergo a facile amine-induced carbocyclisation under mild reaction conditions, yielding densely functionalised cyclopentanones containing chiral quaternary carbon centres